Axim Biotechnologies Stock Price, News & Analysis
Company Description
Axim Biotechnologies (OTC Link: AXIM) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.7M.
AXIM stock has gained 103.1% over the past year. Shares last traded at $0.0065.
On a trailing twelve-month basis, Axim Biotechnologies reported revenue of $40K with net income of -$8.1M and diluted earnings per share of $-0.04. The company operates at a net profit margin of -20395.0%.
This page provides a comprehensive overview of AXIM stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Axim Biotechnologies (AXIM) stock last traded at $0.0065, up 5.38% from the previous close. Over the past 12 months, the stock has gained 103.1%. At a market capitalization of $1.7M, AXIM is classified as a micro-cap stock with approximately 333.0M shares outstanding.
Latest News
Axim Biotechnologies has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include partnership, management, fda approval. View all AXIM news →
SEC Filings
Financial Highlights
Axim Biotechnologies generated $40K in revenue over the trailing twelve months, operating income reached -$2.8M (-6961.0% operating margin), and net income was -$8.1M, reflecting a -20395.0% net profit margin. Diluted earnings per share stood at $-0.04. The company generated -$1.0M in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Axim Biotechnologies (AXIM) currently stands at 112.2 thousand shares, up 1000.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 653.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Axim Biotechnologies (AXIM) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.9 days.
AXIM Company Profile & Sector Positioning
Axim Biotechnologies (AXIM) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing AXIM often look at related companies in the same sector, including Vaccinex Inc (VCNX), Algernon Health (AGNPF), Galera Therapeutics, Inc. (GRTX), Enzolytics (ENZC), and Ayala Pharm (ADXS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AXIM's relative position within its industry.